These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
189 related items for PubMed ID: 35102541
1. Overexpression of lncRNA IRAIN restrains the progression and Temozolomide resistance of glioma via repressing IGF-1R-PI3K-NF-κB signaling pathway. Guo A, Fang G, Lin Z, Zheng S, Zhuang Z, Lin R, Lin Y. Histol Histopathol; 2022 Jun; 37(6):543-554. PubMed ID: 35102541 [Abstract] [Full Text] [Related]
2. MSC-AS1 knockdown inhibits cell growth and temozolomide resistance by regulating miR-373-3p/CPEB4 axis in glioma through PI3K/Akt pathway. Li C, Feng S, Chen L. Mol Cell Biochem; 2021 Feb; 476(2):699-713. PubMed ID: 33106913 [Abstract] [Full Text] [Related]
3. Long noncoding RNA LIFR-AS1 suppresses proliferation, migration and invasion and promotes apoptosis through modulating miR-4262/NF-κB pathway in glioma. Ding H, Cui L, Wang C. Neurol Res; 2021 Mar; 43(3):210-219. PubMed ID: 33070767 [Abstract] [Full Text] [Related]
4. Mechanisms for hypoxia-induced long non-coding small nucleolar RNA host gene 14 in promoting temozolomide resistance of glioma. Zhao H, Meng L, Liao X, Liu Y, Mo X, Gong M, Liao Y. Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Jul 28; 47(7):829-838. PubMed ID: 36039578 [Abstract] [Full Text] [Related]
5. Long Non-Coding RNA LINC01260 Inhibits the Proliferation, Migration and Invasion of Spinal Cord Glioma Cells by Targeting CARD11 Via the NF-κB Signaling Pathway. Wu DM, Han XR, Wen X, Wang S, Wang YJ, Shen M, Fan SH, Zhuang J, Zhang ZF, Shan Q, Li MQ, Hu B, Sun CH, Lu J, Zheng YL. Cell Physiol Biochem; 2018 Jul 28; 48(4):1563-1578. PubMed ID: 30071522 [Abstract] [Full Text] [Related]
8. Long non-coding RNA LINC00152/miR-613/CD164 axis regulates cell proliferation, apoptosis, migration and invasion in glioma via PI3K/AKT pathway. Zhang L, Wang Y, Su H. Neoplasma; 2020 Jul 28; 67(4):762-772. PubMed ID: 32726126 [Abstract] [Full Text] [Related]
9. MicroRNA-146b-5p/EPHA7 axis regulates cell invasion, metastasis, proliferation, and temozolomide-induced chemoresistance via regulation of IRAK4/TRAF6/NF-κB signaling pathway in aggressive pituitary adenoma. Lou X, Cai Y, Zheng H, Zhang Y. Histol Histopathol; 2022 Jan 28; 37(1):21-33. PubMed ID: 34746996 [Abstract] [Full Text] [Related]
10. IGFBP6 controls the expansion of chemoresistant glioblastoma through paracrine IGF2/IGF-1R signaling. Oliva CR, Halloran B, Hjelmeland AB, Vazquez A, Bailey SM, Sarkaria JN, Griguer CE. Cell Commun Signal; 2018 Sep 19; 16(1):61. PubMed ID: 30231881 [Abstract] [Full Text] [Related]
11. Long noncoding RNA DANCR mediates cisplatin resistance in glioma cells via activating AXL/PI3K/Akt/NF-κB signaling pathway. Ma Y, Zhou G, Li M, Hu D, Zhang L, Liu P, Lin K. Neurochem Int; 2018 Sep 19; 118():233-241. PubMed ID: 29572052 [Abstract] [Full Text] [Related]
12. Salvianolic acid A (Sal A) suppresses malignant progression of glioma and enhances temozolomide (TMZ) sensitivity via repressing transgelin-2 (TAGLN2) mediated phosphatidylinositol-3-kinase (PI3K) / protein kinase B (Akt) pathway. Ye T, Chen R, Zhou Y, Zhang J, Zhang Z, Wei H, Xu Y, Wang Y, Zhang Y. Bioengineered; 2022 May 19; 13(5):11646-11655. PubMed ID: 35505656 [Abstract] [Full Text] [Related]
13. Knockdown of circHIPK3 Facilitates Temozolomide Sensitivity in Glioma by Regulating Cellular Behaviors Through miR-524-5p/KIF2A-Mediated PI3K/AKT Pathway. Yin H, Cui X. Cancer Biother Radiopharm; 2021 Sep 19; 36(7):556-567. PubMed ID: 32833501 [Abstract] [Full Text] [Related]
14. lncRNA MEG3 Inhibits the Proliferation and Growth of Glioma Cells by Downregulating Bcl-xL in the PI3K/Akt/NF-κB Signal Pathway. Jia H, Yan X. Biomed Res Int; 2022 Sep 19; 2022():3729069. PubMed ID: 35860793 [Abstract] [Full Text] [Related]
15. Guggulsterone from Commiphora mukul potentiates anti-glioblastoma efficacy of temozolomide in vitro and in vivo via down-regulating EGFR/PI3K/Akt signaling and NF-κB activation. Xu HB, Chen XZ, Yu ZL, Xue F. J Ethnopharmacol; 2023 Jan 30; 301():115855. PubMed ID: 36280019 [Abstract] [Full Text] [Related]
16. lncRNA XLOC013218 promotes cell proliferation and TMZ resistance by targeting the PIK3R2-mediated PI3K/AKT pathway in glioma. Zhou J, Xu N, Liu B, Wang C, He Z, Lenahan C, Tang W, Zeng H, Guo H. Cancer Sci; 2022 Aug 30; 113(8):2681-2692. PubMed ID: 35637600 [Abstract] [Full Text] [Related]
17. Knockdown of lncRNA LSINCT5 suppresses growth and metastasis of human glioma cells via up-regulating miR-451. Liu B, Cao W, Ma H. Artif Cells Nanomed Biotechnol; 2019 Dec 30; 47(1):2507-2515. PubMed ID: 31213092 [Abstract] [Full Text] [Related]
18. lncRNA TUG1 inhibits the cancer stem cell‑like properties of temozolomide‑resistant glioma cells by interacting with EZH2. Cao Y, Chai W, Wang Y, Tang D, Shao D, Song H, Long J. Mol Med Rep; 2021 Jul 30; 24(1):. PubMed ID: 34036375 [Abstract] [Full Text] [Related]
19. LncRNA-ATB promotes TGF-β-induced glioma cells invasion through NF-κB and P38/MAPK pathway. Tang F, Wang H, Chen E, Bian E, Xu Y, Ji X, Yang Z, Hua X, Zhang Y, Zhao B. J Cell Physiol; 2019 Dec 30; 234(12):23302-23314. PubMed ID: 31140621 [Abstract] [Full Text] [Related]
20. lncRNA EZR‑AS1 knockdown represses proliferation, migration and invasion of cSCC via the PI3K/AKT signaling pathway. Lu D, Sun L, Li Z, Mu Z. Mol Med Rep; 2021 Jan 30; 23(1):. PubMed ID: 33236153 [Abstract] [Full Text] [Related] Page: [Next] [New Search]